Investing
Nano Dimension Buys Stratasys, Bristol Myers's Shopping Spree, Apple Gets a 'No'
Published:
The holiday shopping season isn’t over yet. A 3-D printing company and a major pharmaceuticals maker announced post-Christmas acquisitions Tuesday morning.
Bristol Myers makes another buy
Last Friday, Bristol Myers Squibb Co. (NYSE: BMY) announced that it will acquire drug developer Karuna Therapeutics Inc. (NASDAQ: KRTX) for $330 per share in cash. Tuesday morning, Bristol Myers announced that it has agreed to acquire RayzeBio Inc. (NASDAQ: RYZB), a radiopharmaceutical developer, for $62.50 per share. The all-cash deal values RayzeBio at $3.6 billion net of around $500 million in cash.
Bristol Myers’s offer represents a premium of 104.4% to RayzeBio’s Friday closing price of $30.57. Bristol Myers said the acquisition, which is expected to close in the first quarter, will reduce adjusted EPS by $0.13 per share in 2024. The Karuna acquisition will reduce 2024 earnings by around $0.30 per share according to Bristol Myers.
Both acquisitions will be financed with new debt. Bristol Myers had $7.7 billion in cash and other liquidity at the end of the third quarter. The company also had $32.2 billion in long-term debt.
RayzeBio stock traded up by about 97% at $60.25 in Tuesday’s premarket session. The stock’s 52-week range is $17.95 to $31.11. The high was posted last Friday.
Bristol Myers stock traded up about 0.2% early Tuesday at $52.39 in a 52-week range of $48.25 to $75.18. (The 7 Highest Yielding ‘Strong Buy’ Dividend Kings You Can Buy and Hold Forever)
Nano Dimension pushes harder on Stratasys
Israel-based 3D printing firm Nano Dimension Ltd. (NASDAQ: NNDM) is tired of waiting for Stratasys Ltd. (NASDAQ: SSYS) to break its silence. Since late September, when Stratasys announced a strategic review, including a possible sale of the company, Nano Dimension has had its hand raised.
Nano already owns 14% of Stratasys and is its largest shareholder. Because Nano is getting the silent treatment, it decided to make public its preliminary offer to acquire Stratasys for $16.50 per share. The price reflects a premium of 40% to Stratasys’s share price at the time of the company’s September announcement of the strategic review.
Stratasys stock closed at $11.75 when the strategic review was announced and closed at $13.11 last Friday. The stock traded up 12.2% in Tuesday’s premarket at $14.71.
Nano Dimension stock traded flat early Tuesday at $2.40 per share in a 52-week range of $2.16 to $3.35.
Apple gets no help
Last week, Apple Inc. (NASDAQ: AAPL) began removing certain models of its Apple Watch from its stores. U.S. Trade Representative Katherine Tai declined to reverse an October ruling that Apple infringed on two Masimo Corp. (NASDAQ: MASI) patents that use light sensors to measure a person’s blood oxygen levels.
While Apple can appeal the ITC’s decision, it had 60 days to comply with the October ruling. That 60-day period ended on December 26.
The Average American Is Losing Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.
Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.
But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
